A systematic literature review of the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and stem cell transplants-Reference-Cited by-同舟云学术

A systematic literature review of the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and stem cell transplants

Published:2020-09-01 Issue:9 Volume:16 Page:911-921
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Monleón Bonet Clara¹,Waser Nathalie²,Cheng Karen³,Tzivelekis Spiros⁴,Edgar J. David M.⁵,Sánchez-Ramón Silvia⁶^ORCID

Affiliation:

1. Global Evidence and Outcomes, Immunology, Takeda Pharmaceuticals International AG, Zurich, Switzerland

2. Real World Evidence Strategy and Analytics, ICON Plc, Vancouver, Canada

3. formerly in Global Medical Affairs, Rare Immunology, Takeda Pharmaceuticals International AG, Zurich, Switzerland

4. Global Evidence & Outcomes Hematology, Takeda, Cambridge, MA

5. Department of Immunology, St James’s Hospital and Trinity College Dublin, Dublin, Ireland

6. Departmento de Inmunologia Clinica, Hospital Clinico San Carlos and Universidad Complutense of Madrid, Madrid, Spain

Funder

. provided editorial support, which was

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2020.1807328

Reference47 articles.

1. Secondary immunodeficiencies, including HIV infection

2. Secondary antibody deficiencies

3. Secondary antibody deficiency – causes and approach to diagnosis

4. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management

5. Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional study;Int. Journal of Clinical Pharmacology and Therapeutics;2024-07-30

2. Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen;Int. Journal of Clinical Pharmacology and Therapeutics;2024-06-01

3. Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies;Blood Advances;2024-05-14

4. A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies;International Journal of Technology Assessment in Health Care;2024

5. Access and use of immunoglobulins in supportive cancer care: A thematic analysis of a systematic review data set;The Journal of Medicine Access;2024-01